Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pressley, J.C.
Right arrow Articles by Mayeux, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pressley, J.C.
Right arrow Articles by Mayeux, R.
Related Collections
Right arrow Cost effectiveness/economic
Right arrow Parkinson's disease/Parkinsonism

Neurology 2003;60:87-93
© 2003 American Academy of Neurology

The impact of comorbid disease and injuries on resource use and expenditures in parkinsonism

J.C. Pressley, PhD MPH, E.D. Louis, MD MS, M.-X. Tang, PhD, L. Cote, MD, P.D. Cohen, PhD, S. Glied, PhD and R. Mayeux, MD MSc

From the Gertrude H. Sergievsky Center (Drs. Pressley, Louis, Tang, Cote, and Mayeux), The School of Public Health, and Departments of Health Policy and Management (Drs. Pressley and Glied), Biostatistics (Dr. Tang), Epidemiology (Dr. Mayeux), and Neurology (Drs. Louis, Cote, and Mayeux), the College of Physicians and Surgeons, Columbia University, New York, NY; and the PD Foundation (Dr. Cohen), Program on Quality, Access and Delivery of Parkinson Care (QuADPaC), Washington, DC.

Address correspondence and reprint requests to Dr. Joyce C. Pressley, Columbia University, College of Physicians and Surgeons, 630 West 168th St. PH19, New York, NY 10032; e-mail: jp376{at}columbia.edu

Background: Persons with parkinsonism have high rates of both associated and unrelated prevalent comorbid conditions. A better understanding of patterns of care and expenditures may aid in designing programs to enhance functioning, lengthen independent living, and manage costs.

Methods: The authors linked national survey data of 24,831 elderly to nearly 1.9 million Medicare claims. Persons with parkinsonism (n = 791) were identified from survey or Medicare encounters for paralysis agitans. Comorbid disease risk was measured using age-adjusted OR with 95% CI. Comorbidity cost ratios (ratio of average per person per year charges for parkinsonism alone vs with comorbid conditions) were developed to describe incremental costs of comorbidities.

Results: Patients with parkinsonism were older (78.5 ± 7.6 vs 75.1 ± 8.3 years, p < 0.0001) and had more injuries resulting in broken bones (35.6% vs 19.5%, p < 0.0001), including broken hips (15.9% vs 5.8%, p < 0.0001), during the 5-year study. Broken hips were more prevalent among men (OR 3.4, 95% CI 2.5 to 4.8) and women (OR 2.5, 95% CI 2.1 to 3.1) with than without parkinsonism. Among those with parkinsonism, comorbidity cost ratios demonstrated two- to threefold higher charges for dementia, broken bones, broken hip, and diabetes.

Conclusions: Comorbidity associated with parkinsonism is an under-recognized contribution to higher resource use and expenditures. Further study of injuries, dementia, and diabetes is required to assess whether public health interventions could reduce excess morbidity and expenditures associated with parkinsonism.




This article has been cited by other articles:


Home page
J Am Acad Orthop SurgHome page
L. M. Zuckerman
Parkinson's Disease and the Orthopaedic Patient
J. Am. Acad. Ortho. Surg., January 1, 2009; 17(1): 48 - 55.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
J. A. Driver, A. Smith, J. E. Buring, J. M. Gaziano, T. Kurth, and G. Logroscino
Prospective Cohort Study of Type 2 Diabetes and the Risk of Parkinson's Disease
Diabetes Care, October 1, 2008; 31(10): 2003 - 2005.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
C. Becker, G. P. Brobert, S. Johansson, S. S. Jick, and C. R. Meier
Diabetes in Patients With Idiopathic Parkinson's Disease
Diabetes Care, September 1, 2008; 31(9): 1808 - 1812.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
G. Logroscino, H. D. Sesso, R. S. Paffenbarger Jr, and I-M. Lee
Body Mass Index and Risk of Parkinson's Disease: A Prospective Cohort Study
Am. J. Epidemiol., November 15, 2007; 166(10): 1186 - 1190.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
G. Hu, P. Jousilahti, S. Bidel, R. Antikainen, and J. Tuomilehto
Type 2 Diabetes and the Risk of Parkinson's Disease
Diabetes Care, April 1, 2007; 30(4): 842 - 847.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
G Logroscino, H D Sesso, R S Paffenbarger Jr, and I-M Lee
Physical activity and risk of Parkinson's disease: a prospective cohort study
J. Neurol. Neurosurg. Psychiatry, December 1, 2006; 77(12): 1318 - 1322.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
B. R. Bloem, M. Munneke, M. G. Carpenter, J. H.J. Allum, and J. C. Pressley
The impact of comorbid disease and injuries on resource use and expenditures in parkinsonism
Neurology, October 14, 2003; 61(7): 1023 - 1023.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by AAN Enterprises, Inc.